UBS Maintains Buy on Helmerich & Payne, Raises Price Target to $50
UBS analyst Josh Silverstein maintains Helmerich & Payne (NYSE:HP) with a Buy and raises the price target from $49 to $50.
Stocks · News reference
Helmerich & Payne Expects Fiscal Q4 Direct Margins At Or Near High End Of Guidance In All Segments, International About $45M
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Barclays Maintains Overweight on Helmerich & Payne, Raises Price Target to $51
Barclays analyst Eddie Kim maintains Helmerich & Payne (NYSE:HP) with a Overweight and raises the price target from $50 to $51.
Helmerich & Payne Q3 2026 Earnings Call Transcript
On Thursday, Helmerich & Payne (NYSE:HP) discussed third-quarter financial results during its earnings call. The full transcript is provided below. Benzinga APIs provide real-time access to earnings call transcripts
8-K filing — Helmerich & Payne, Inc. (HP)
Filed: 2026-10-07 AccNo: 0000046765-26-000055 Size: 532 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits